SJD · Integrated Continuous Glucose Ketone Monitoring System, Factory Calibrated

Clinical Chemistry · 21 CFR 862.1354 · Class 2

Overview

Product CodeSJD
Device NameIntegrated Continuous Glucose Ketone Monitoring System, Factory Calibrated
Regulation21 CFR 862.1354
Device ClassClass 2
Review PanelClinical Chemistry

Identification

The Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System is a prescription device indicated for the management of diabetes in persons age 2 years and older. It is intended to monitor glucose and ketone (beta-hydroxybutyrate) levels in real-time. The system provides alarms, detects trends, tracks glucose and ketone patterns, and aids in the detection of episodes of hyperglycemia, hypoglycemia, and hyperketonemia. It replaces blood glucose testing for diabetes treatment decisions and is intended to autonomously communicate with digitally connected devices for the purpose of managing diabetes.

Classification Rationale

FDA has determined that the device can be classified in class II with the establishment of special controls for class II. FDA believes that class II (special) controls provide reasonable assurance of the safety and effectiveness of the device type.

Recent Cleared Devices (1 of 1)

RecordDevice NameApplicantDecision DateDecision
DEN250049Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring SystemAbbott Diabetes CareAug 25, 2026DENG

Top Applicants

Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...